The World Allergy Market 2006-2011 - The Rx-OTC Rush

Why is the World Allergies Market Important?

The number of people suffering from some sort of allergy is on the rise and the demand for reliable treatments for allergic rhinitis and other allergic conditions is on the rise worldwide. The market is a mature one with a number of high profile patent losses in the near future and a strong OTC segment. Will there be a replacement for Zyrtec or Allegra in the near Future? What role will the new improved vaccines play in the next five years? Read visiongain’s new report to find out.

What is contained in the report?

The report covers all aspects of the current allergy market, including

> A brief introduction into the biology of allergies

> A market forecast for the world prescription market 2006-2011

> Geographic breakdowns for sales revenues

> A SWOT analysis of the allergic rhinitis market

> Summaries and forecasts for the leading antihistamines and corticosteroids

> An assessment of the drivers and restraints of the market

> A discussion of the strategy of Rx-OTC switching

> A review of the OTC market for allergic rhinitis

> Analysis of treatments of eczema and allergic conjunctivitis

> This report consists of over 100 pages and over 50 tables and figures.

Lead Analyst: Dr Tom Newton Publication Date: 12/10/06 Pages: 116

Single user licence: The Report is delivered via an on-line reading room. One use access only, the report is in Flash format in a printable format.

Department: Report is delivered via an on line reading room. Five user access only, the report is in Flash format in a printable format.

Company/site wide licence: The report is delivered in email format as a PDF document with no locking system attached. The report can be loaded onto the company's intranet site.
Table of Contents

Price
Single Use Licence $2500.00
Department Licence 5 Users $5000.00
Company-wide Intranet Licence $8750.00
Company over 2500 employees $11750.00